Connect with us

Technology

Ceva, Inc. Announces Third Quarter 2024 Financial Results

Published

on

– Total revenue of $27.2 million, up 13% year-over-year
– Ceva-powered device shipments of 522 million units in the quarter, driven by a record of more than 400 million Bluetooth, Wi-Fi and cellular IoT combined shipments 
– Strategic licensing deals signed with satellite OEM for 5G-Advanced platform and smartphone OEM for Spatial Audio software
– First licensing deal signed for NeuPro-Nano embedded AI NPU targeting consumer AIoT
– Raises financial guidance for full year 2024
– Announces expansion of existing share repurchase program with an additional 700,000 shares

ROCKVILLE, Md., Nov. 7, 2024 /PRNewswire/ — Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP that enables Smart Edge devices to connect, sense and infer data more reliably and efficiently, today announced its financial results for the third quarter ended September 30, 2024. Financial results for the third quarter ended September 30, 2023, reflect Ceva’s continuing operations only, with the Intrinsix business reflected as a discontinued operation, unless otherwise noted.

Operational Highlights:

Released second NeuPro-Nano embedded AI NPU – NPN64, available for licensingNew cellular IoT industrial module launched by STMicroelectronics based on Ceva cellular IoT platformNew AI/ML MCU family launched by Alif Semiconductor based on Ceva Bluetooth Low Energy and 802.15.4 IPsPartnership with Edge Impulse to enable faster, easier development of edge AI applications on Ceva-NeuPro NPUs

Total revenue for the third quarter of 2024 was $27.2 million, up 13% compared to $24.1 million reported for the third quarter of 2023. Licensing and related revenue for the third quarter of 2024 was $15.6 million, up 12% compared to $13.9 million reported for the same quarter a year ago. Royalty revenue for the third quarter of 2024 was $11.6 million, the fourth sequential year-over-year increase, and up 15% compared to $10.1 million reported for the same quarter a year ago.

Amir Panush, Chief Executive Officer of Ceva, commented: “We delivered another strong performance in the third quarter, driven by double-digit year-over-year revenue growth for both licensing and royalties. We continue to experience exceptional demand for our IP portfolio, as evidenced by strategic OEM customer deals for 5G-Advanced satellite communications and spatial audio for headphones and earbuds. We also achieved a significant milestone in embedded AI, with our first licensing deal signed for our NeuPro-Nano NPU targeting consumer AIoT devices. In royalties, strength in the consumer and industrial markets drove Ceva-powered shipments to the second highest quarter on record, including record combined shipments of Bluetooth, Wi-Fi and cellular IoT devices of more than 400 million units.”  

During the quarter, 10 IP licensing agreements were concluded, targeting a wide range of end markets and applications, including embedded AI solutions for consumer AIoT devices, 5G-Advanced satellite broadband for infrastructure and terminals, 5G for cellular IoT and V2X, spatial audio for headphones and TWS earbuds, and Bluetooth, Wi-Fi and UWB connectivity for wearables and hearables. Three of the deals signed in the quarter were with OEMs and three deals signed were with first-time customers.

GAAP gross margin for the third quarter of 2024 was 85%, as compared to 90% in the third quarter of 2023. GAAP operating loss for the third quarter of 2024 was $2.6 million, as compared to a GAAP operating loss of $2.7 million for the same period in 2023. GAAP net loss for the third quarter of 2024 was $1.3 million, as compared to a GAAP net loss of $2.8 million reported for the same period in 2023. GAAP diluted loss per share for the third quarter of 2024 was $0.06, as compared to GAAP diluted loss per share of $0.12 for the same period in 2023.

GAAP net loss with the discontinued operation for the third quarter of 2023 was $5.0 million. GAAP diluted loss per share with the discontinued operation for the third quarter of 2023 was $0.21.

Non-GAAP gross margin for the third quarter of 2024 was 87%, as compared to 92% for the same period in 2023. Non-GAAP operating income for the third quarter of 2024 increased 30% to $2.1 million, as compared to non-GAAP operating income of $1.6 million reported for the third quarter of 2023. Non-GAAP net income and diluted income per share for the third quarter of 2024 increased 137% and 133% to $3.4 million and $0.14, respectively, compared with non-GAAP net income and diluted income per share of $1.4 million and $0.06, respectively, reported for the third quarter of 2023. 

Non-GAAP net income, including the discontinued operation for the third quarter of 2023, was $0.4 million. Non-GAAP diluted income per share, including the discontinued operation for the third quarter of 2023, was $0.02.

Yaniv Arieli, Chief Financial Officer of Ceva, stated: “Our robust third quarter earnings more than doubled our non-GAAP net income and diluted income per share year-over-year. For the full year, we now expect overall revenues to be higher than previous guidance, at a new range of 7%-9% growth, enabling us to double our non-GAAP fully diluted EPS year-over-year. We continued to buy back the company’s stock during the quarter, repurchasing approximately 186,000 shares for approximately $4.2 million under our stock repurchase program. Furthermore, the Ceva Board of Directors today authorized the expansion of the company’s share repurchase program with an additional 700,000 shares of common stock available for repurchase, bringing the total shares available for repurchase to approximately 1 million. At the end of the quarter, our cash and cash equivalent balances, marketable securities and bank deposits were approximately $158 million, ensuring we are well-positioned to explore opportunities for non-organic growth.”

Ceva Conference Call
On November 7, 2024, Ceva management will conduct a conference call at 8:30 a.m. Eastern Time to discuss the operating performance for the quarter.

The conference call will be available via the following dial in numbers:

U.S. Participants : Dial 1-844-435-0316 (Access Code : Ceva)International Participants: Dial +1-412-317-6365 (Access Code: Ceva)

The conference call will also be available live via webcast at the following link: https://app.webinar.net/pyMYRB4aBXo. Please go to the web site at least fifteen minutes prior to the call to register.

For those who cannot access the live broadcast, a replay will be available by dialing +1-877-344-7529 or +1-412-317-0088 (access code: 2106460) from one hour after the end of the call until 9:00 a.m. (Eastern Time) on November 14, 2024. The replay will also be available at Ceva’s web site www.ceva-ip.com.

Forward Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties, as well as assumptions that if they materialize or prove incorrect, could cause the results of Ceva to differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements include statements regarding customer demand for Ceva’s IP portfolio, Ceva’s positioning for non-organic growth given its current assets and updated guidance for the full year 2024. The risks, uncertainties and assumptions that could cause differing Ceva results include: the effect of intense industry competition; the ability of Ceva’s technologies and products incorporating Ceva’s technologies to achieve market acceptance; Ceva’s ability to meet changing needs of end-users and evolving market demands; the cyclical nature of and general economic conditions in the semiconductor industry; Ceva’s ability to diversify its royalty streams and license revenues; Ceva’s ability to continue to generate significant revenues from the handset baseband market and to penetrate new markets; instability and disruptions related to the ongoing IsraelGaza conflict; and general market conditions and other risks relating to Ceva’s business, including, but not limited to, those that are described from time to time in our SEC filings. Ceva assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

Non-GAAP Financial Measures

Non-GAAP gross margin for both the third quarter of 2024 and 2023 excluded: (a) equity-based compensation expenses of $0.2 million and (b) amortization of acquired intangibles of $0.1 million.

Non-GAAP operating income for the third quarter of 2024 excluded: (a) equity-based compensation expenses of $4.2 million, (b) the impact of the amortization of acquired intangibles of $0.3 million and (c) $0.3 million of costs associated with business acquisitions.

Non-GAAP operating income for the third quarter of 2023 excluded: (a) equity-based compensation expenses of $4.0 million, (b) the impact of the amortization of acquired intangibles of $0.3 million and (c) $0.1 million of costs associated with business acquisitions.

Non-GAAP net income and diluted income per share for the third quarter of 2024 excluded: (a) equity-based compensation expenses of $4.2 million, (b) the impact of the amortization of acquired intangibles of $0.3 million, (c) $0.3 million of costs associated with business acquisitions and (d) Income of $0.02 million associated with the remeasurement of marketable equity securities. Non-GAAP net income and diluted income per share for the third quarter of 2023 excluded: (a) equity-based compensation expenses of $4.0 million, (b) the impact of the amortization of acquired intangibles of $0.3 million, (c) $0.1 million of costs associated with business acquisitions and (d) Income of $0.2 million associated with the remeasurement of marketable equity securities.

Non-GAAP net income including the discontinued operation and diluted income per share including the discontinued operation for the third quarter of 2023 excluded: (a) equity-based compensation expenses of $4.0 million, (b) the impact of the amortization of acquired intangibles of $0.3 million, (c) $0.1 million of costs associated with business acquisitions, (d) Income of $0.2 million associated with the remeasurement of marketable equity securities and (e) $1.2 million loss associated with discontinued operations.

About Ceva, Inc.

At Ceva, we are passionate about bringing new levels of innovation to the smart edge. Our wireless communications, sensing and Edge AI technologies are at the heart of some of today’s most advanced smart edge products. From wireless connectivity IPs (Bluetooth, Wi-Fi, UWB and 5G platform IP), to scalable Edge AI NPU IPs and sensor fusion solutions, we have the broadest portfolio of IP to connect, sense and infer data more reliably and efficiently. We deliver differentiated solutions that combine outstanding performance at ultra-low power within a very small silicon footprint. Our goal is simple – to deliver the silicon and software IP to enable a smarter, safer, and more interconnected world. This philosophy is in practice today, with Ceva powering more than 18 billion of the world’s most innovative smart edge products from AI-infused smartwatches, IoT devices and wearables to autonomous vehicles and 5G mobile networks.

Our headquarters are in Rockville, Maryland with a global customer base supported by operations worldwide. Our employees are among the leading experts in their areas of specialty, consistently solving the most complex design challenges, enabling our customers to bring innovative smart edge products to market.

Ceva is a sustainability- and environmentally-conscious company, adhering to our Code of Business Conduct and Ethics. As such, we emphasize and focus on environmental preservation, recycling, the welfare of our employees and privacy – which we promote on a corporate level. At Ceva, we are committed to social responsibility, values of preservation and consciousness towards these purposes.

Ceva: Powering the Smart Edge™

Visit us at www.ceva-ip.com and follow us on LinkedIn, X, YouTubeFacebook, and Instagram.

Ceva, Inc. AND ITS SUBSIDIARIES

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF LOSS – U.S. GAAP

U.S. dollars in thousands, except per share data

Three months ended

Nine months ended

September 30,

September 30,

2024

2023

2024

2023

Unaudited

Unaudited

Unaudited

Unaudited

Revenues:

Licensing and related revenues

$  15,574

$  13,940

$  44,266

$  45,739

Royalties

11,633

10,133

33,450

27,518

Total revenues

27,207

24,073

77,716

73,257

Cost of revenues

3,961

2,357

9,397

9,389

Gross profit

23,246

21,716

68,319

63,868

Operating expenses:

Research and development, net

17,990

17,814

54,739

54,544

Sales and marketing

3,088

2,862

8,999

8,213

General and administrative

4,642

3,608

11,751

11,346

Amortization of intangible assets

150

149

449

445

Total operating expenses

25,870

24,433

75,938

74,548

Operating loss

(2,624)

(2,717)

(7,619)

(10,680)

Financial income, net

2,299

924

4,962

3,497

Reevaluation of marketable equity securities

21

160

(97)

(76)

Loss before taxes on income

(304)

(1,633)

(2,754)

(7,259)

Income tax expense

1,007

1,117

4,296

3,080

Net loss from continuing operation

(1,311)

(2,750)

(7,050)

(10,339)

Discontinued operation

(2,207)

(5,308)

Net loss

$  (1,311)

$  (4,957)

$  (7,050)

$  (15,647)

Basic and diluted net loss per share:

               Continuing operation

$   (0.06)

$   (0.12)

$   (0.30)

$   (0.44)

               Discontinued operation

(0.09)

(0.23)

Basic and diluted net loss per share

$   (0.06)

$   (0.21)

$   (0.30)

$   (0.67)

Weighted-average shares used to compute net loss
per share (in thousands):

Basic and diluted

23,678

23,605

23,605

23,473

 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

U.S. Dollars in thousands, except per share amounts

Three months ended

Nine months ended

September 30,

September 30,

2024

2023

2024

2023

Unaudited

Unaudited

Unaudited

Unaudited

GAAP net loss

$  (1,311)

$  (4,957)

$  (7,050)

$  (15,647)

Equity-based compensation expense included in cost of
revenues

176

216

570

636

Equity-based compensation expense included in research
and development expenses

2,421

2,257

6,866

6,703

Equity-based compensation expense included in sales
and marketing expenses

491

478

1,307

1,305

Equity-based compensation expense included in general
and administrative expenses

1,120

1,018

2,936

2,787

Amortization of intangible assets related to acquisition
of businesses

279

278

835

753

Costs associated with business and asset acquisitions

251

100

783

195

(Income) loss associated with the remeasurement of
marketable equity securities

(21)

(160)

97

76

Non-GAAP from discontinued operations

1,184

3,233

Non-GAAP net income

$  3,406

$  414

$  6,344

$  41

GAAP weighted-average number of Common Stock
used in computation of diluted net loss and loss per share
(in thousands)

23,678

23,605

23,605

23,473

Weighted-average number of shares related to
outstanding stock-based awards (in thousands)

1,544

1,304

1,462

1,172

Weighted-average number of Common Stock used in
computation of diluted earnings per share, excluding the
above (in thousands)

25,222

24,909

25,067

24,645

GAAP diluted loss per share

$  (0.06)

$  (0.21)

$  (0.30)

$  (0.67)

Equity-based compensation expense

$  0.18

$  0.17

$  0.48

$  0.49

Amortization of intangible assets related to acquisition
of businesses

$  0.01

$  0.01

$  0.04

$  0.03

Costs associated with business and asset acquisitions

$  0.01

$  0.00

$  0.03

$  0.01

Income (loss) associated with the remeasurement of
marketable equity securities

$  0.00

$  0.00

$  0.00

$  0.00

Non-GAAP from discontinued operation

$  0.05

$  0.14

Non-GAAP diluted earnings  per share

$  0.14

$  0.02

$  0.25

$  0.00

 

Three months ended

Nine months ended

September 30,

September 30,

2024

2023

2024

2023

Unaudited

Unaudited

Unaudited

Unaudited

GAAP Operating loss

$  (2,624)

$  (2,717)

$  (7,619)

$  (10,680)

Equity-based compensation expense included in cost of
revenues

176

216

570

636

Equity-based compensation expense included in
research and development expenses

2,421

2,257

6,866

6,703

Equity-based compensation expense included in sales
and marketing expenses

491

478

1,307

1,305

Equity-based compensation expense included in
general and administrative expenses

1,120

1,018

2,936

2,787

Amortization of intangible assets related to acquisition
of businesses

279

278

835

753

Costs associated with business and asset acquisitions

251

100

783

195

Total non-GAAP Operating Income 

$  2,114

$  1,630

$  5,678

$  1,699

 

Three months ended

Nine months ended

September 30,

September 30,

2024

2023

2024

2023

Unaudited

Unaudited

Unaudited

Unaudited

GAAP Gross Profit

$  23,246

$  21,716

$  68,319

$  63,868

GAAP Gross Margin

85 %

90 %

88 %

87 %

Equity-based compensation expense included in cost of
revenues

176

216

570

636

Amortization of intangible assets related to acquisition
of businesses

129

129

386

308

Total Non-GAAP Gross profit

$  23,551

$  22,061

$  69,275

$  64,812

Non-GAAP Gross Margin

87 %

92 %

89 %

88 %

 

Ceva, Inc. AND ITS SUBSIDIARIES

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. Dollars in thousands)

September 30,

December 31,

2024

2023 (*)

Unaudited

Unaudited

ASSETS

Current assets:

Cash and cash equivalents

$  13,228

$  23,287

Marketable securities and short-term bank deposits

144,884

143,251

Trade receivables, net

15,250

8,433

Unbilled receivables

23,380

21,874

Prepaid expenses and other current assets

13,970

12,526

Total current assets

210,712

209,371

Long-term assets:

Severance pay fund

6,851

7,070

Deferred tax assets, net

1,685

1,609

Property and equipment, net

6,875

6,732

Operating lease right-of-use assets

5,625

6,978

Investment in marketable equity securities

309

406

Goodwill

58,308

58,308

Intangible assets, net

2,132

2,967

Other long-term assets

12,394

10,644

Total assets

$  304,891

$  304,085

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Trade payables

$  1,960

$  1,154

Deferred revenues

3,418

3,018

Accrued expenses and other payables

19,770

20,202

Operating lease liabilities

2,571

2,513

Total current liabilities

27,719

26,887

Long-term liabilities:

    Accrued severance pay

7,304

7,524

Operating lease liabilities

2,627

3,943

Other accrued liabilities

1,471

1,390

Total liabilities

39,121

39,744

Stockholders’ equity:

Common stock

24

23

Additional paid in-capital

256,685

252,100

Treasury stock

(2,943)

(5,620)

Accumulated other comprehensive loss

(956)

(2,329)

Retained earnings

12,960

20,167

Total stockholders’ equity

265,770

264,341

Total liabilities and stockholders’ equity

$  304,891

$  304,085

(*) Derived from audited financial statements.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ceva-inc-announces-third-quarter-2024-financial-results-302298072.html

SOURCE Ceva, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

First season of NWSL on ION: 50 matches, 53 studio shows, 130+ hours of content, 20.5 million unique viewers

Published

on

By

CINCINNATI, Nov. 7, 2024 /PRNewswire/ — The first season of National Women’s Soccer League on ION broadcasts – matches and studio shows – reached more than 20.5 million total unique viewers, including 13.5 viewers unique to ION.

Scripps Sports televised Saturday night doubleheaders on ION throughout the season, a total of 50 matches – more than any other network – and 53 studio shows. ION was among the networks involved in a landmark multi-year distribution agreement announced in November 2023 that included CBS Sports, ESPN and Prime Video.

ION, the only network to have a weekly studio show with documentary-style features on players and coaches, delivered more than 130 hours of NWSL content during the season. ION is a national sports and entertainment broadcast network that reaches every U.S. TV household over-the-air and on all major pay TV and connected TV services. ION is owned by The E.W. Scripps Company (Nasdaq: SSP).

Highlights of NWSL on ION Season 1*:

ION delivered the largest female percentage audience of any network (57% of the P25-54 audience, 55% of the P2+ audience).50% of all NWSL viewers watched matches on ION, the highest percentage of all linear broadcast partners.Matches drew an average audience of 145,000 P2+ per game with a high of 234,000 on July 6 for the OrlandoKansas City match.NWSL matches on ION delivered more than 3.6 million hours of viewing across free ad-supported television (FAST) channels, including Roku, Samsung TV, LG, Vizio, Xumo, Plex, Amazon Fire TV Channels, Pluto, CW and Tablo.Scripps Sports formed more than two dozen advertising partnerships, including Capital One as presenting sponsor of NWSL on ION Saturday Night soccer.

“NWSL fans consistently showed up to watch ION every week,” Scripps Sports President Brian Lawlor said. “It was an incredible first year. We expect to continue growing the audience and helping the league grow its fan base.”

“Our matches on ION brought incredible NWSL content to fans everywhere,” said Brian Gordon, NWSL senior vice president of broadcast. “Beyond the matches, the ability to go in depth with our athletes and give them a platform to amplify their own stories helped our fans grow an even deeper affinity for the players, clubs and league. We are very proud of our collaboration with Scripps Sports and look forward to continuing our work together next season.”

*Sources for data: Nielsen L+SD national panel one-minute qualifier for reach. Data for NWSL+, Prime Video and Paramount+ is not available.

Scripps media contact: Michael Perry, (513) 259-4718, michael.perry@scripps.com
NWSL contact: Jennifer Levine, (917) 921-7806, jlevine@nwslsoccer.com

Scripps Sports serves professional and college sports leagues, conferences and teams with local market depth and national broadcast reach. Scripps Sports currently has partnerships with the Women’s National Basketball Association (WNBA), the National Women’s Soccer League (NWSL), the National Hockey League’s (NHL) 2024 Stanley Cup champion Florida Panthers, the 2023 Stanley Cup champion Vegas Golden Knights, the new Utah Hockey Club and the NCAA’s Big Sky Conference. Scripps Sports is a division of The E.W. Scripps Company (NASDAQ: SSP), a Fortune 1000 American media company. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/first-season-of-nwsl-on-ion-50-matches-53-studio-shows-130-hours-of-content-20-5-million-unique-viewers-302298952.html

SOURCE The E.W. Scripps Company

Continue Reading

Technology

Jaime L. Cook Appointed Vice President of Operations and Market Development at Linear Integrated Systems, Inc.

Published

on

By

FREMONT, Calif., Nov. 7, 2024 /PRNewswire/ — Linear Integrated Systems, Inc. is pleased to announce the appointment of Jaime L. Cook as Vice President of Operations and Market Development. In this pivotal role, Ms. Cook will oversee all operational functions and spearhead market development initiatives.

Jaime Cook has been a valued member of the Linear Systems team since 2009. Before assuming her new role, Ms. Cook served as Sales Manager, Director of Sales, and VP of Operations, gaining extensive experience across multiple facets of the company. Ms. Cook brings a wealth of knowledge and expertise to her position as VP of Operations & Market Development. She holds bachelor’s degrees in Real Estate and Land Use, as well as Strategic Management. Her education, certifications, and work experience have honed her skills in strategic planning, negotiation, and relationship building—qualities that significantly contribute to her expanded responsibilities at Linear Systems.

“I’m incredibly proud to have built my career at Linear Systems and to be part of a team of exceptional individuals committed to producing the industry’s best specialty linear semiconductors while consistently meeting the highest standards of performance and reliability,” said Cook. “I am excited to expand my responsibilities, drive operational excellence, and lead efforts to explore new market opportunities.”

Cindy L. Johnson, CEO of Linear Systems, stated, “Jaime’s leadership in operations and market development is pivotal as we aim to expand our product reach and strengthen customer relationships. Her strategic vision is vital to our mission of delivering ultra-reliable JFETs and other components that enable our clients to achieve outstanding performance in their designs.”

Founded 37 years ago by John M. Hall, Cindy L. Johnson, and John H. Hall, Linear Integrated Systems, Inc. is a privately held designer and manufacturer of small-signal discrete semiconductors based in Fremont, CA. John H. Hall, a co-founder of Intersil and the founder of Micro Power Systems, brought significant expertise and innovation to the company.

Linear Systems offers a diverse product line, including Dual JFET Amplifiers, Single JFET Amplifiers, JFET Switches, DMOS High Speed Switches, Low Leakage Diodes, Current Regulating Diodes, Bipolar Transistors, MOSFETs, Voltage Controlled Resistors and BIFET Amplifiers. Visit www.linearsystems.com to download our 2024 Data Book, Cross Reference Guide, datasheets, SPICE models, application notes, and more.

Stay connected and join our growing LinkedIn community for updates and insights. You can also follow us on YouTube, Facebook, Instagram and X.

Contact:
Laura Madonna

laura@linearsystems.com
Phone: (510) 490-9160
Website: www.linearsystems.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/jaime-l-cook-appointed-vice-president-of-operations-and-market-development-at-linear-integrated-systems-inc-302298015.html

SOURCE Linear Integrated Systems

Continue Reading

Technology

Mammotome Introduces the First Ever, Single Insertion, Spring-Loaded Core Biopsy System

Published

on

By

CINCINNATI, Nov. 7, 2024 /PRNewswire/ — Mammotome is excited to unveil the Mammotome AutoCore™ Single Insertion Core Biopsy System, the first automated spring-loaded core needle device on the market.1 This innovative launch highlights the company’s unwavering dedication to pioneering breast biopsy technology and improving patient care.

The Mammotome AutoCore™ system offers significant advantages over traditional core needle devices, saving valuable time for physicians and improving the patient experience.2 Developed with efficiency and ergonomics in mind, the single insertion design simplifies ultrasound-guided biopsies by reducing procedural steps.3,4

The system features single-button functionality with automated arming, allowing the user to perform all sampling steps with one button. This eliminates manual arming and enables easy one-handed operation. Designed for touchless tissue transfer, samples are automatically collected in a clear, illuminated cup positioned in front of the user’s hand. A wiper arm moves each sample from the aperture to the cup, eliminating the need to remove and reinsert the needle between samples. Once all samples are obtained, the tissue collection cup can be removed and placed directly into formalin. This innovation reduces procedural steps and time while allowing physicians to maintain visual focus on the lesion, ensuring precise sampling.2,3,4

“Mammotome is dedicated to providing innovative solutions that improve the biopsy experience for both patients and physicians,” said Karen Isaacs, Vice President of Engineering and R&D at Mammotome. “The Mammotome AutoCore™ system is the first core needle device of its kind, bringing in a new era of efficiency for ultrasound core needle breast biopsies. The launch of this device is a testament to our ongoing dedication to innovation and excellence in breast care.”

The Mammotome AutoCore™ system is now FDA cleared in the United States and will be available to clinicians domestically in early 2025, with plans to expand to other select countries across the globe.

To learn more about the Mammotome AutoCore™ system, click here.

About Mammotome
At Mammotome, our expertise and compassion for breast care makes us the indispensable partner to physicians, clinicians and patients. Our drive for innovation is rivaled only by our compassion for the people we serve, from the clinicians and surgeons who demand consistently precise solutions, to the patients and families seeking peace of mind. We boast a comprehensive range of products that create better outcomes in breast care and provide physicians and patients with educational resources that guide their journey. Headquartered in Cincinnati, Ohio, Mammotome is proud to be a part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health. The Mammotome brand of products is sold in over 65 different countries throughout the world.

Automated means automatic arming and tissue collection at the press of a button.As compared to market leading, spring-loaded core needle or multiple insertion devices. Based on IFU analysis in ultrasound-guided breast biopsy procedures. Total procedure steps savings based on biopsy procedure taking five tissue samples including setup and post-procedure steps. On average, based on internal study using varied customer tissue handling techniques. Tissue handling techniques determined by user interviews. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/mammotome-introduces-the-first-ever-single-insertion-spring-loaded-core-biopsy-system-302298945.html

SOURCE MAMMOTOME

Continue Reading

Trending